1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60B23D2B18648D91000258C0D004FE205
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-hematology-medical-insights-management-team-structure-effectiveness-lessons-learned?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Hematology Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned

ID: 5845


Features:

21 Info Graphics

30 Data Graphics

360+ Metrics

11 Narratives


Pages/Slides: 63


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Hematology Medical Insights Management: Team Structure, Effectiveness, and Lessons Learned”

STUDY OVERVIEW

Hematology-focused Medical Affairs teams must structure and streamline their insight dissemination processes to ensure seamless communication across the organization and drive impactful decision-making. However, many struggle to build a well-defined framework that ensures timely and accurate insights.

This benchmarking research by Best Practices, LLC explores how Hematology-focused Medical Affairs groups can enhance the effectiveness of their insight dissemination efforts. It highlights proven models, benchmarks, and critical lessons from industry leaders for building high-performing dissemination frameworks.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in hematology medical insight generation: Insight Majority (18 respondents) and Insight Laggards (4 respondents).


KEY TOPICS

  • Structure of Hematology Medical Insights and Dissemination Group
  • Disseminating Hematology Insights: Tools, Activities and Effectiveness
  • Best Practices and Key Lessons Learned
  • Actionable Insights and Intelligence Gathering in Hematology

KEY METRICS

  • Presence of a separate group that gathers and disseminates hematology insights for Medical Affairs – Total benchmark class, Insight Majority, and Insight Laggards
  • Role of each of the groups within Medical Affairs for both gathering and disseminating hematology insights – Total benchmark class, Insight Majority, and Insight Laggards
  • Roles of Medical Affairs sub-functions in gathering and disseminating hematology insights – Insight Majority and Insight Laggards
  • Lead and support role of Medical Affairs groups in gathering and disseminating hematology insights – Total benchmark class
  • Level of expertise of the person who is responsible for conveying hematology medical insights to other functions – Total benchmark class, Insight Majority, and Insight Laggards
  • Strengths and weaknesses of hematology insights gathering and dissemination group structure
  • Breakdown of intelligence deliverables types in hematology – Total benchmark class, Insight Majority, and Insight Laggards
  • Tools used by Hematology Medical teams to deliver insights to other functions – Total benchmark class, Insight Majority, and Insight Laggards
  • Effectiveness and importance of digital tools used by the Hematology Medical Affairs team to gather, evaluate, and disseminate intelligence – Total benchmark class, Insight Majority, and Insight Laggards
  • Additional methods used by Hematology Medical Affairs teams to gather intelligence (beyond KOL and HCP engagement)

SAMPLE KEY FINDINGS

  • Insight Gathering Process and Its Effectiveness: Only a quarter of hematology participants have a stand-alone group dedicated to insights. Most rely on various subfunctions to coordinate multiple activities for gathering and inputting data into a system. Coordination across other inter-functional groups is attempted, often with limited success.

METHODOLOGY

Best Practices, LLC engaged 22 executives from 17 leading life sciences companies focused on hematology for this research. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care


Companies Profiled:
Agios; Apellis Pharmaceuticals; ApotheCom; Bayer; Eli Lilly and Company; Genentech; Janssen; Merck; Mesoblast; Novo Nordisk; Orchard Therapeutics; Roche; Sandoz; Servier; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Teva Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.